Loading...
Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Ciprofloxacin, the first fluoroquinolone to be used to treat lower respiratory tract infections (LRTI), demonstrates poor potency against Streptococcus pneumoniae, and its use has been associated with the emergence of resistance. During the last decade, fluoroquinolones with enhanced in vitro activi...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3147653/ https://ncbi.nlm.nih.gov/pubmed/21628545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00237-11 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|